menu
    • menu

    Company profile for Specialised Therapeutics

    NEW Drugs in Dev: 8
    FAMAR CDMO- From early development to commercial manufacturing.

    Virtual Booth

    Contact Supplier

    Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    AbbVie Contract Manufacturing partners globally to develop, scale, and manufacture pharmaceutical products successfully.

    Virtual Booth

    Contact Supplier

    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Specialised Therapeutics is an international biopharmaceutical company with strategic focus and expertise in Australia, New Zealand and South East Asia. We partner with global pharmaceutical companies to champion their products from pre-registration through to full commercialisation, maintaining consistent, globally-aligned brand identities. Every team member at Specialised Therapeutics contributes to this process, bring...
    Specialised Therapeutics is an international biopharmaceutical company with strategic focus and expertise in Australia, New Zealand and South East Asia. We partner with global pharmaceutical companies to champion their products from pre-registration through to full commercialisation, maintaining consistent, globally-aligned brand identities. Every team member at Specialised Therapeutics contributes to this process, bringing extensive industry experience acquired in large international biopharmaceutical companies. With expertise, we strategically navigate the complex regulatory and reimbursement pathways in these diverse markets.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Specialised TherapeuticsAustralia Flag
    Country
    Country
    Australia
    Address
    Address
    Level 2, 17 Cotham Road Kew, Victoria 3101
    Telephone
    Telephone
    1300 798 820
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://stabiopharma.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    PEGS Boston Summit

    PEGS Boston Summit

    Not Confirmed

    envelop Contact Supplier

    PEGS Boston Summit

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Australia Approves First-in-Class cGVHD Therapy
    Australia Approves First-in-Class cGVHD Therapy

    03 May 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/new-first-in-class-therapy-for-chronic-graft-versus-host-disease-approved-in-australia1-302760088.html

    PR NEWSWIRE
    03 May 2026
    Share Share
    Minjuvi for R/R Follicular Lymphoma Approved in Australia
    Minjuvi for R/R Follicular Lymphoma Approved in Australia

    23 Apr 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/minjuvi-tafasitamab-for-relapsed-or-refractory-follicular-lymphoma-approved-in-australia-302751394.html

    PR NEWSWIRE
    23 Apr 2026
    Share Share
    New Breast Cancer Therapy Cuts Recurrence Risk in Thailand
    New Breast Cancer Therapy Cuts Recurrence Risk in Thailand

    22 Jan 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/new-breast-cancer-therapy-to-reduce-risk-of-recurrence-and-improve-disease-free-survival-now-available-in-thailand-302666471.html

    PR NEWSWIRE
    22 Jan 2026
    Share Share
    Specialised Therapeutics Expands Incyte Deal With 2 Therapies
    Specialised Therapeutics Expands Incyte Deal With 2 Therapies

    12 Jun 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/specialised-therapeutics-expands-partnership-with-incyte-to-include-two-additional-therapies-for-hard-to-treat-conditions-302479723.html

    PR NEWSWIRE
    12 Jun 2025
    Share Share
    New Therapy for Children with Growth Hormone Deficiency Approved
    New Therapy for Children with Growth Hormone Deficiency Approved

    28 May 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/new-therapy-for-children-with-growth-hormone-deficiency-approved-in-australia-302468041.html

    PR NEWSWIRE
    28 May 2025
    Share Share
    First & Only Treatment For Hypoparathyroidism Approved In Australia
    First & Only Treatment For Hypoparathyroidism Approved In Australia

    20 Feb 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/first-and-only-treatment-for-chronic-hypoparathyroidism-approved-in-australia-302381167.html

    PR NEWSWIRE
    20 Feb 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search